À propos
Actions
Données et outils
Évenements
Actualités
WFH statement - EN

La FDA propose une évaluation individuelle des risques pour les dons de sang, dans le cadre d’une révision des politiques d’éligibilité et d’exclusion des donneurs et donneuses aux États-Unis

La Food and Drug Administration (FDA) des États-Unis a annoncé sa proposition d’abandonner les exclusions basées sur les délais pour évaluer l’éligibilité des donneurs de donneuses de sang, au profit de questions individuelles et inclusives en matière de genre, pour réduire le risque de transmission du VIH par transfusion.

Aussi disponible en : English Español

Cette proposition s’aligne sur les politiques en place dans des pays comme le Royaume-Uni et le Canada. Les recommandations rédigées par la FDA se fondent sur l’examen attentif par l’agence des informations disponibles, notamment de données provenant d’autres pays présentant une épidémiologie similaire du VIH et qui ont adopté cette approche, ainsi que sur la surveillance active des stocks de sang des États-Unis.

Pour lire le communiqué de presse intégral de la FDA (en anglais), cliquez ici.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.